Perioperative immune function and pain control may underlie early hospital readmission and 90 day mortality following lung cancer resection: A prospective cohort study of 932 patients.

Affiliation

University of Birmingham, Birmingham, United Kingdom. Electronic address: [Email]

Abstract

Mortality following lung cancer resection has been shown to double between 30 and 90 days and readmission following surgery is associated with an increased risk of mortality. The aim of this study was to describe the causes of readmission and mortality and enable the identification of potentially modifiable factors associated with these events.

Keywords

Lung cancer,Mortality,Outcomes,Readmission,Thoracic surgery,

OUR Recent Articles